Sareum Holdings (SAR)
14/11/2017 - 12:05 RNS
RNS Number: 4679W Sareum Holdings PLC 14 November 2017 (AIM: SAR) 14 November 2017 Sareum Holdings plc ("Sareum" or "the Company") Placing Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, announces that it has raised 700,000, before expenses, through a placement via Hybridan LLP as agent of the Comp...
31/10/2017 - 10:02 StockMarketWire
Sareum Holdings has noted that Sierra Oncology, the licence holder advancing a clinical cancer candidate Chk1 inhibitor, r...
31/10/2017 - 07:00 RNS
RNS Number: 0638V Sareum Holdings PLC 31 October 2017 (AIM: SAR) 31 October 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy - SRA737 demonstrates synergy with replication stress-inducing agents - - SRA737 plus gemci...
19/10/2017 - 08:28 StockMarketWire
Sareum, a cancer drug discovery and development company, made a maiden profit after tax on ordinary activities of 400...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment